Rhythm Pharma Gets $21M A Round to Target Obesity - Xconomy
Tuesday, March 16th, 2010Rhythm Pharma Gets $21M A Round to Target Obesity - XconomyThe potential riches for makers of obesity and diabetes treatments are irresistible to biotech entrepreneurs and investors. Rhythm Pharmaceuticals, a drug developer focused on these multibillion-dollar markets, has closed a $21 million Series A round